Profile of Working-Age Patients with Keloid and Hypertrophic Scar at Dr. Soetomo General Hospital Surabaya in 2014-2017
Methods: This was descriptive retrospective study evaluating 105 patients treated for keloid and hypertrophic scar from 2014 to 2017 using medical records of working-age patients.
Results: Mostly in patients between 17-25 years old (40%). Comparison between male and female patients were 1.07:1 (keloid) and 1.09:1 (hypertrophic scar). As many as 10.71% of patients of keloid and 17.39% patients of hypertrophic scar were private employees. 23.21% patients with keloid and 23.91% patients of hypertrophic scar were Javanese. 14.29% patients of keloid and 19.57% patients of hypertrophic scar tend to have daily indoor activities. 17.86% patients of keloid and 26.09% patients of hypertrophic scar felt dark-skinned toned. Most keloid scars were caused by traumatic lesions (32.14%), located on the chest (19.54%), and treated by corticosteroid injection. Hypertrophic scar mostly caused by burn injury (54.35%), located on the face (29.55%), and treated by excision surgery.
Conclusion: Both keloid and hypertrophic scars were mostly developed in 17-25 years old, male, private employees, Javanese ethnic, dark skin tone patients, with daily indoor activities, caused by traumatic lesion and located on the chest, earlobe, and hand, treated by corticosteroid injection (keloid). Meanwhile, hypertrophic scars are mostly caused by a burn injury on the face and treated by excision surgery.
Andisi RDS, Suling PL, Kapantow MG. Profil Keloid di Poliklinik Kulit dan Kelamin RSUP Prof. Dr. R. D. Kandou Manado Periode Januari 2011-Desember 2015. J e-Clinic; 4. Epub ahead of print 2016. DOI: https://doi.org/10.35790/ecl.v4i2.14667.
Gefilem G. Profil Tumor Jinak Kulit di Poliklinik Kulit dan Kelamin RSUP Prof. Dr. R. D Kandou Manado Periode 2009-2011. J e-Clinic; 1. Epub ahead of print 2013. DOI: https://doi.org/10.35790/ecl.v1i1.3291.
Baker R, Urso-Baiarda F, Linge C, et al. Cutaneous Scarring: A Clinical Review. Dermatol Res Pract 2009; 2009: 625376.
Nugraha A, Chaidir R, Rahayu U, et al. Factors Influencing the Occurrence of Hypertrophic Scars among Postoperative Patients in Garut, Indonesia. Belitung Nurs J 2017; 3: 23–31.
Ogawa R. Keloid and Hypertrophic Scars are the Result of Chronic Inflammation in the Reticular Dermis. Int J Mol Sci; 18. Epub ahead of print March 2017. DOI: 10.3390/ijms18030606.
Pontoriero A, Potami A, Iatì G, et al. Post-Operative Radiotherapy of Keloids. A 10-Years Experience of Kilovoltage Irradiation. Int J Radiat Res 2015; 13: 201–204.
Gauglitz GG, Korting HC, Pavicic T, et al. Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies. Mol Med 2011; 17: 113–125.
Ghazawi FM, Zargham R, Gilardino MS, et al. Insights into the Pathophysiology of Hypertrophic Scars and Keloids: How Do They Differ? Adv Skin Wound Care 2018; 31: 582–595.
Rabello FB, Souza CD, Farina Júnior JA. Update on Hypertrophic Scar Treatment. Clinics (Sao Paulo) 2014; 69: 565–573.
Mari W, Alsabri SG, Tabal N, et al. Novel Insights on Understanding of Keloid Scar: Article Review. J Am Coll Clin Wound Spec 2015; 7: 1–7.
Gao F-L, Jin R, Zhang L, et al. The Contribution of Melanocytes to Pathological Scar Formation during Wound Healing. Int J Clin Exp Med 2013; 6: 609–613.
Bock O, Schmid-Ott G, Malewski P, et al. Quality of Life of Patients with Keloid and Hypertrophic Scarring. Arch Dermatol Res 2006; 297: 433–438.
Ravisankar P, Koushik OS, Himaja V, et al. Acne-Causes and Amazing Remedial Measures for Acne. J Pharm Res; 5.
Park TH, Seo SW, Kim JK, et al. Management of Chest Keloids. J Cardiothorac Surg 2011; 6: 49.
Mutalik S. Treatment of Keloids and Hypertrophic Scars. Indian J Dermatol Venereol Leprol 2005; 71: 3–8.
Pratiwi KD, Perdanakusuma D. Hubungan Antara Golongan Darah dengan Timbulnya Keloid Pascaluka. 2009; 5: 1–8.
Shaheen A, Khaddam J, Kesh F. Risk Factors of Keloids in Syrians. BMC Dermatol 2016; 16: 13.
Dyal CM. Investigation of Predictive Factors in Keloid Formation. Yale University, 1989.
Thompson CM, Hocking AM, Honari S, et al. Genetic Risk Factors for Hypertrophic Scar Development. J Burn Care Res 2013; 34: 477–482.
Nast A, Eming S, Fluhr J, et al. German S2k Guidelines for the Therapy of Pathological Scars (Hypertrophic Scars and Keloids). J Dtsch Dermatol Ges 2012; 10: 747–762.
Hochman B, Farkas CB, Isoldi FC, et al. Keloid and Hypertrophic Scar Distribution according to Fitzpatrick Skin Phototypes. Rev Bras Cir Plástica–The Brazilian J Plast Surg 2012; 2727: 185–189.
Sasongko RH, Rahmadewi. Penatalaksanaan Skar Akne (Acne Scar Management). Berk Ilmu Kesehat Kulit dan Kelamin 2011; 23: 234–239.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).